Differential production of cytokines and activation of NF-kappa B in HPV-transformed keratinocytes

[en] We have proposed that chronic infection of keratinocytes by HPV modifies the expression of potentially important cytokines by interfering with the NF-kappaB signal pathway We evaluated the constitutive and IL-1beta-induced expression of GM-CSF and TNF-alpha and the expression/activity of NF-kappaB in HPV+ and HPV- cell lines. Despite the enhanced expression of the functional components of the NF-kappaB signaling pathway in HPV+ cell lines by a mechanism implicating the HPV oncoprotein E6, the constitutive activity of NF-kappaB and the expression of GM-CSF/TNF-alpha were significantly reduced relative to the HPV- cell line and normal keratinocytes. In contrast, we observed a superactivation of NF-kappaB activity after IL-1beta stimulation, a strong and transient induction of GM-CSF/TNF-alpha mRNA, but undetectable levels of secreted proteins in HPV+ cell lines. Our data demonstrate that E6 modulates the NF-kappaB signaling pathway and suggest that other HPV proteins also interfere with GM-CSF/TNF-alpha expression by transcriptional and/or posttranscriptional mechanisms. (C) 2002 Elsevier Science (USA).

Disciplines :

Oncology
Immunology & infectious disease

Author, co-author :

Havard, L.

Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques

Frare, P.

Boniver, Jacques ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques

Giannini, S. L.

Language :

English

Title :

Differential production of cytokines and activation of NF-kappa B in HPV-transformed keratinocytes

Publication date :

05 July 2002

Journal title :

Virology

ISSN :

0042-6822

eISSN :

1096-0341

Publisher :

Academic Press Inc Elsevier Science, San Diego, United States - California

Volume :

298

Issue :

Pages :

271-285

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 29 September 2009

Statistics

Number of views

30 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Al-Saleh W., Giannini S.L., Jacobs N., Moutschen M., Doyen J., Boniver J., Delvenne P. (1998) Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J. Pathol. 184:283-290.
Antinore M.J., Birrer M.J., Patel D., Nader L., McCance D.J. (1996) The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. EMBO J. 15:1950-1960.
Ashburner B.P., Westerheide S.D., Baldwin A.S. (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21:7065-7077.
Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
Barker J.N., Mitra R.S., Griffiths C.E., Dixit V.M., Nickoloff B.J. (1991) Keratinocytes as initiators of inflammation. Lancet 337:211.
Barnard P., McMillan N.A. (1999) The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259:305-313.
Barnard P., Payne E., McMillan N.A. (2000) The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha. Virology 277:411-419.
Beg A.A., Baldwin A.S. (1993) The I kappa B proteins: Multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064-2070.
Ben-Neriah Y. (2002) Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 3:20-26.
Benton C., Shahidullah H., Hunter J.A.A. (1992) Human papillomavirus in the immunosuppressed. Papillomavirus Rep. 3:23-26.
Berezutskaya E., Bagchi S. (1997) The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome. J. Biol. Chem. 272:30135-30140.
Bird T.A., Schooley K., Dower S.K., Hagen H., Virca G.D. (1997) Activation of nuclear transcription factor NF-kappa B by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272:32606-32612.
Brehm A., Nielsen S.J., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., Kouzarides T. (1999) The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 18:2449-2458.
Calore E.E., Cavaliere M.J., Calore N.M. (1998) Squamous intraepithelial lesions in cervical smears of human immunodeficiency virus-seropositive adolescents. Diagn. Cytopathol. 18:91-92.
Chang Y.E., Laimins L.A. (2000) Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74:4174-4182.
Chen L.-F., Fischle W., Verdin E., Greene W.C. (2001) Duration of nuclear NF-kappa B action is regulated by reversible acetylation. Science 293:1653-1657.
Chen S.L., Tsao Y.P., Yang C.M., Lin Y.K., Huang C.H., Kuo S.W. (1995) Differential induction and regulation of c-jun, junB, junD and c-fos by human papillomavirus type 11 E5a oncoprotein. J. Gen. Virol. 76:2653-2659.
Chen S.L., Huang C.H., Tsai T.C., Lu K.Y., Tsao Y.P. (1996) The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein. Arch. Virol. 141:791-800.
Chen T.M., Pecoraro G., Defendi V. (1993) Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53:1167-1171.
Chen Z.J., Parent L., Maniatis T. (1996) Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
Cho Y.S., Kang J.W., Cho M., Cho C.W., Lee S., Choe Y.K., Kim Y., Choi I., Park S.N., Kim S., Dinarello C.A., Yoon D.Y. (2001) Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding of IL-18. FEBS Lett. 501:139-145.
Collart M.A., Baeuerle P., Vassalli P. (1990) Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 10:1498-1506.
Dejardin E., Bonizzi G., Bellahcene A., Castronovo V., Merville M.P., Bours V. (1995) Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11:1835-1841.
DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. (1997) A cytokine-responsive IκB kinase that activates the transcriptional factor NF-κB. Nature 388:548-554.
Ellerbrock T.V., Chiasson M.A., Bush T.J., Sun X.W., Sawo D., Brudney K., Wright T.C.J. (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. J. Am. Med. Assoc. 283:1031-1037.
Enzenauer C., Mengus G., Lavigne A., Davidson I., Pfister H., May M. (1998) Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex. Intervirology 41:80-90.
Franzoso G., Bours V., Park S., Tomita-Yamaguchi M., Kelly K., Siebenlist U. (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 359:339-342.
Friedl F., Kimura I., Osato T., Ito Y. (1970) Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc. Soc. Exp. Biol. Med. 135:543-545.
Giannini S.L., Al-Saleh W., Piron H., Jacobs N., Doyen J., Boniver J., Delvenne P. (1998) Cytokine expression in squamous intraepithelial lesions of the uterine cervix: Implications for the generation of local immunosuppression. Clin. Exp. Immunol. 113:183-189.
Gilles C., Piette J., Rombouts S., Laurent C., Foidart J.M. (1993) Immortalization of human cervical keratinocytes by human papillomavirus type 33. Int. J. Cancer 53:872-879.
Gramigni C., Penco S., Bianchi-Scarra G., Ravazzolo R., Garre C. (1998) An upstream negative regulatory element in human granulocyte-macrophage colony-stimulating factor promoter is recognised by AP1 family members. FEBS. Lett. 440:119-124.
Gross-Mesilaty S., Reinstein E., Bercovich B., Tobias K.E., Schwartz A.L., Kahana C., Ciechanover A. (1998) Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. USA 95:8058-8063.
Hershko A., Ciechanover A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
Hirano F., Chung M., Tanaka H., Maruyama N., Makino I., Moore D.D., Scheidereit C. (1998) Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells. Mol. Cell. Biol. 18:2596-2607.
Hu Y., Baud V., Delhase M., Zhang P., Derrinck T., Ellisman M., Johnson R., Karin M. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IκB kinase. Science 284:316-320.
Hu Y., Baud V., Oga T., Kim K.I., Yoshida K., Karin M. (2001) IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410:710-714.
Hubert P., Van den Brule F., Giannini S.L., Franzen-Detrooz E., Boniver J., Delvenne P. (1999) Colonization of in-vitro formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells: Role of granulocyte/macrophage colony-stimulating factor. Am. J. Pathol. 154:775-784.
Jonuleit H., Knop J., Enk A.H. (1996) Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch. Dermatol. Res. 289:1-8.
Karin M. (1999) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274:27339-27342.
Karin M. (1999) How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 18:6867-6874.
Karin M., Ben-Neriah Y. (2000) Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
Kimber I., Cumberbatch M. (1992) Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J. Invest. Dermatol. 99.
Kornitzer D., Ciechanover A. (2000) Modes of regulation of ubiquitin-mediated protein degradation. J. Cell. Physiol. 182:1-11.
Koromilas A.E., Li S., Matlashewski G. (2001) Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev. 12:157-170.
Kothny-Wilkes G., Kulms D., Poppelmann B., Luger T.A., Kubin M., Schwarz T. (1998) Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 273:29247-29253.
Kothny-Wilkes G., Kulms D., Luger T.A., Kubin M., Schwarz T. (1999) Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis. J. Biol. Chem. 274:28916-28921.
Lee S.J., Cho Y.S., Cho M.C., Shim J.H., Lee K.A., Ko K.K., Choe Y.K., Park S.N., Hoshino T., Kim S., Dinarello C.A., Yoon D.Y. (2001) Both e6 and e7 oncoproteins of human papillomavirus inhibit il-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells. J. Immunol. 167:497-504.
Li C.C., Dai R.M., Chen E., Longo D.L. (1994) Phosphorylation of NF-KB1-p50 is involved in NF-kappa B activation and stable DNA binding. J. Biol. Chem. 269:30089-30092.
Li C.C., Korner M., Ferris D.K., Chen E., Dai R.M., Longo D.L. (1994) NF-kappa B-Rel family members are physically associated phosphoproteins. Biochem. J. 303:499-506.
Li S., Labrecque S., Gauzzi M.C., Cuddihy A.R., Wong A.H., Pellegrini S., Matlashewski G.J., Koromilas A.E. (1999) The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727-5737.
Li Q., Lu Q., Hwang J.Y., Buscher D., Lee K.F., Izpisua-Belmonte J.C., Verma I.M. (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322-1328.
Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M. (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1839-1845.
MacGregor G.R., Mogg A.E., Burke J.F., Caskey C.T. (1987) Histochemical staining of clonal mammalian cell lines expressing E.coli β galactosidase indicates heterogeneous expression of the bacterial gene. Somat. Cell. Mol. Gen. 13:253-265.
Mantovani F., Banks L. (1999) The interaction between p53 and papillomaviruses. Semin. Cancer Biol. 9:387-395.
Massimi P., Pim D., Storey A., Banks L. (1996) HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12:2325-2330.
Meissner J.D. (1999) Nucleotide sequences and further characterization of human papillomavirus DNA present in the CasKi, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80:1725-1733.
Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. (1997) IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278:860-866.
Mota F., Rayment N., Chong S., Singer A., Chain B. (1999) The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin. Exp. Immunol. 116:33-40.
Musso M., Ghiorzo P., Fiorentini P., Giuffrida R., Ciotti P., Garre C., Ravazzolo R., Bianchi-Scarra G. (1996) An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kappa B/Rel family members. Biochem. Biophys. Res. Commun. 223:64-72.
Naumann M., Scheidereit C. (1994) Activation of NF-kappa B in vivo is regulated by multiple phopshorylations. EMBO J. 13:4597-4607.
Nees M., Geoghegan J.M., Hyman T., Frank S., Miller L., Woodworth C.D. (2001) Papillomavirus type 16 oncogenes down-regulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J. Virol. 75:4283-4296.
Park J.S., Kim E.J., Kwon H.J., Hwang E.S., Namkoong S.E., Um S.J. (2000) Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 275:6764-6769.
Parkin S.M., Laara E., Muir C.S. (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer 41:184-197.
Patel D., Huang S.-M., Baglia L.A., McCance D.J. (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18:5061-5072.
Pattillo R.A., Hussa R.O., Story M.T., Ruckert A.C., Shalaby M.R., Mattingly R.F. (1977) Tumor antigen and human chorionic gonadotropin in CaSki cells: A new epidermoid cervical cancer cell line. Science 196:1456-1458.
Perea S.E., Massimi P., Banks L. (2000) Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int. J. Mol. Med. 5:661-666.
Petry K.U., Scheffel D., Bode U. (1994) Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int. J. Cancer 57:836-840.
Qin J.-Z., Chaturvedi V., Denning M.F., Choubey D., Diaz M.O., Nickoloff B.J. (1999) Role of NF-κB in the apoptotic-resistant phenotype of keratinocytes. J. Biol. Chem. 274:37957-37964.
Rhoades K.L., Golub S.H., Economou J.S. (1992) The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J. Biol. Chem. 267:22102-22107.
Rice N.R., Ernst M.K. (1993) In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J. 12:4685-4695.
Richart R.M. (1967) The natural history of cervical intraepithelial neoplasia. Clin. Obstet. Gynecol. 10:748-784.
Richart R.M. (1987) Causes and management of cervical intraepithelial neoplasia. Cancer 60:1951-1959.
Riethdorf L., Riethdorf S., Gutzlaff K., Prall F., Loning T. (1996) Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am. J. Pathol. 149:1469-1476.
Riethdorf S., Riethdorf L., Richter N., Loning T. (1998) Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases. Pathobiology 66:260-267.
Ronco L.V., Karpova A.Y., Vidal M., Howley P.M. (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:2061-2072.
Rosl F., Lengert M., Albrecht J., Kleine K., Zawatzky R., Schraven B., Zur Hausen H. (1994) Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J. Virol. 68:2142-2150.
Rothwarf D.M., Zandi E., Natoli G., Karin M. (1998) IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395:297-300.
Scheffner M., Munger K., Byrne J.C., Howley P.M. (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523-5527.
Schreck R., Baeuerle P.A. (1990) NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol. 10:1281-1286.
Seitz C.S., Lin Q., Deng H., Khavari P.A. (1998) Alterations in NF-kappaB function in in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc. Natl. Acad. Sci. USA 95:2307-2312.
Seitz C.S., Deng H., Hinata K., Lin Q., Khavari P.A. (2000) Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res. 60:4085-4092.
Seitz C.S., Freiberg R.A., Hinata K., Khavari P.A. (2000) NF-kappaB determines localization and features of cell death in epidermis. J. Clin. Invest. 105:253-260.
Sherman L., Alloul N., Golan I., Durst M., Baram A. (1992) Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Int. J. Cancer 50:356-364.
Shirakawa F., Chedid M., Suttles J., Pollok B.A., Mizel S.B. (1989) Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein. Mol. Cell. Biol. 9:959-964.
Soto U., Das B.C., Lengert M., Finzer P., Zur Hausen H., Rosl F. (1999) Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 18:3187-3198.
Stylianou E., O'Neill L.A., Rawlinson L., Edbrooke M.R., Woo P., Saklatvala J. (1992) Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J. Biol. Chem. 267:15836-15841.
Takeda K., Takeuchi O., Tsujimura T., Itami S., Adachi O., Kawai T., Sanjo H., Yoshikawa K., Terada N., Akira S. (1999) Limb and skin abnormalities in mice lacking IKKalpha. Science 284:313-316.
Tartour E., Gey A., Sastre-Garau X., Pannetier C., Mosseri V., Kourilsky P., Fridman W.H. (1994) Analysis of interleukin 6 gene expression in cervical neoplasia using quantitative polymerase chain reaction assay: Evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res. 54:6243-6248.
Thomas R.S., Tymms M.J., McKinlay L.H., Shannon M.F., Seth A., Kola I. (1997) ETS1, NFkappaB and AP1 synergistically trans-activate the human GM-CSF promoter. Oncogene 14:2845-2855.
Tsao Y.P., Huang C.H., Lin Y.K., Chen S.L. (1995) Protein kinase C- and ras-dependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein. Cancer Lett. 95:201-205.
Udalova I.A., Knight J.C., Vidal V., Nedospasov S.A., Kwiatkowski D. (1998) Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273:21178-21186.
Vancurova I., Wu R., Miskolci V., Sun S. (2002) Increased p50/p50 NF-kappa B activation in human papillomavirus type 6- or 11-induced laryngeal papilloma tissue. J. Virol. 76:1533-1536.
Van Hogerlinden M., Rozell B.L., Ahrlund-Richter L., Toftgard R. (1999) Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 59:3299-3303.
Vincenti M.P., Burrell T.A., Taffet S.M. (1992) Regulation of NF-kappa B activity in murine macrophages: Effect of bacterial lipopolysaccharide and phorbol ester. J. Cell. Physiol. 150:204-213.
Witmer-Pack M.D., Olivier W., Valinsky J., Schuler G., Steinman R.M. (1987) Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166:1484-1498.
Woodworth C.D., Simpson S. (1993) Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am. J. Pathol. 142:1544-1555.
Yao J., Mackman N., Edgington T.S., Fan S.T. (1997) Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J. Biol. Chem. 272:17795-17801.
Yoshida K., Hu Y., Karin M. (2000) IkappaB kinase alpha is essential for development of the mammalian cornea conjunctiva. Invest. Ophthalmol. Vis. Sci. 41:3665-3669.
Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. (1997) The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91:243-252.
Zandi E., Chen Y., Karin M. (1998) Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: Discrimination between free and NF-kappaB-bound substrate. Science 281:1360-1363.
Zhong H., Voll R.E., Ghosh S. (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1:661-671.